OGB-23503

N/A

Report date: 2024/11/15 19:16:47

Base Information

Drug NameOGB-23503

Drug Alias NameOGB23503

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed cell death protein 1 blockersVascular endothelial growth factor inhibitorsT cell immunoglobulin and ITIM domains inhibitors

TargetsProgrammed cell death protein 1Vascular endothelial growth factorT cell immunoglobulin and ITIM domains

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOnegene Biotechnology Inc

China Registration ClassN/A

Develop Information

Active CompaniesOnegene Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A